A research study titled, “Bioabsorbable Stents Market
by Biomaterial, Application, and End User - Global Industry Analysis and
Forecast to 2025” published by Crystal Market Research, states that the
bioabsorbable stents market is projected to be around $8 billion by 2025.
Cardiovascular disorders majorly affect the
geriatric population worldwide. These people are more vulnerable to heart
related ailments such as strokes and cardiac arrests. Bioabsorbable stents
offer more benefits as compared to traditional stents in applications such as
angioplasty and peripheral artery related disorders. Bioabsorbable implants
outperform with respect to traditional stents which remain as permanent foreign
bodies inside the artery after their intended use. Such prolonged stay may
result in mechanical blockages or late restenosis. Therefore, rise in adoption
of bioabsorbable stents globally will drive the growth of this market over the
forecast period.
Polymeric stents are widely used in treating
cardiovascular diseases. By using bioabsorbable polymeric coating, thrombotic
event can be considerably reduced. It can also eliminate the need for extended
dual anti platelet therapy. Poly-L-Lactic is one of the polymers used in
polymeric stents which breaks down the lactic acid into natural metabolites.
Later it converts into water and metabolized carbon dioxide. Magnesium
bioabsorbable stent is the most widely used metallic stent for management of
cardiac diseases. Solubility is one of the major determining factors for using
metal alloys in metallic stents.
Browse
full research report with TOC @ http://www.crystalmarketresearch.com/report/bioabsorbable-stents-market
Coronary artery disease market will exhibit the
fastest growth over the forecast period as they have crucial applications in
the treatment of coronary artery disorders. These diseases may escalate to
heart attacks in certain cases. Peripheral artery diseases can be attributed to
narrowing of the peripheral arteries to the arms, legs, and stomach.
Atherosclerosis is one of the prime reasons for the induction of peripheral
artery diseases. If left untreated, these diseases can lead to gangrene
requiring amputation of the body part.
North America held the major share of the
bioabsorbable stents market in 2016 with the U.S. representing the largest
market, followed by Canada. Sedentary lifestyle habits of people have resulted
in rise of cardiovascular disorders in the region. Rising awareness about the
utility of bioabsorbable stents for treating coronary diseases along with
technological advancements in these stents have contributed to the growth of
this regional market. For instance, in 2016, Abbott obtained FDA approval for
its Absorb bioabsorbable stent, which is the only fully dissolvable stent
approved for the treatment of coronary artery disorders. Asia-Pacific market is
anticipated to show a higher growth rate over the forecast period with the
improving healthcare infrastructure in emerging nations as well as growing
disposable income of people.
Request
a sample copy of Bioabsorbable Stents Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0510
The leading companies in bioabsorbable stents market
focus on collaborations and agreements to ensure and further enhance their
share in the market. Some key players in bioabsorbable stents market are
Biotronik, Medtronic plc, Kyoto Medical Planning. Co. Ltd, Reva Medical,
Microport Scientific Corporation, Elixir Medical Corporation, Terumo Europe NV,
and Boston Scientific corporation.
Key Findings of
the Research Study:
·
Polymeric
bioabsorbable stents are widely used in treating cardiovascular diseases which
can reduce the chances of thrombotic events.
·
Coronary
artery disease market is a promising segment expected to show high growth rate
from 2017 to 2025, as bioabsorbable stents play crucial role in the treatment
of coronary artery diseases.
·
North
America was the largest bioabsorbable stents market for in 2016, due to
consistent technological advancements in these stents due to developed
healthcare infrastructure.
·
Asia-Pacific
market will exhibit a high CAGR during the forecast period, due to presence of
high unmet medical needs, rising disposable income of patients, and the
constantly improving healthcare infrastructure.
·
Japan
accounted for the major share of the Asia-Pacific market in 2016, while China
is projected to be the fastest growing country over the forecast period.
About Crystal
Market Research
Crystal Market Research is a U.S. based market
research and business intelligence company. Crystal offers one stop solution
for market research, business intelligence, and consulting services to help
clients make more informed decisions. It provides both syndicated as well as
customized research studies for its customers spread across the globe. The
company offers market intelligence reports across a broad range of industries
including healthcare, chemicals & materials, technology, automotive, and
energy.
Contact:
Akhil
V.
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll
Free: +1-888-213-4282
Website: http://www.crystalmarketresearch.com
No comments:
Post a Comment